Inferior Wall MI Management with Bradycardia

The patient presents with an acute inferior wall myocardial infarction (MI) complicated by hypotension (Blood Pressure [BP] 80/50 mm Hg) and severe bradycardia (Heart Rate [HR] 40/minute) in sinus rhythm. This clinical scenario suggests increased vagal tone, a common occurrence in inferior MIs, leading to the Bezold-Jarisch reflex.

Rationale for Atropine Administration

The most appropriate initial management step is the intravenous administration of atropine sulfate.

• Mechanism: Atropine is an anticholinergic medication that blocks the effect of acetylcholine at the vagus nerve, thereby increasing the heart rate.
• Indication: It is the first-line treatment for symptomatic bradycardia, especially when associated with hypotension and signs of hypoperfusion, particularly in the context of inferior MI where increased vagal tone is suspected.
• Goal: To rapidly increase the heart rate and improve cardiac output, alleviating hypotension and associated symptoms.

Why Other Options Are Less Suitable First Steps

• Normal Saline: While fluid resuscitation may be considered if hypovolemia is suspected, it is not the primary treatment for drug-induced or vagally-mediated bradycardia and hypotension. It might even be detrimental if the patient develops fluid overload.
• Temporary Pacemaker: Pacing is indicated for hemodynamically unstable bradycardia unresponsive to initial medical therapy (like atropine) or when atropine is ineffective or contraindicated. It is a second-line intervention.
• Isoprenaline: This is a beta-agonist used for bradycardia unresponsive to atropine. However, it increases myocardial oxygen demand, which can be harmful in acute MI. It is generally considered after atropine failure.

Therefore, atropine sulfate is the most appropriate initial pharmacological intervention.